Treatment of Attention-Deficit Hyperactivity Disorder in Athletes

被引:13
|
作者
Kutcher, Jeffrey S. [1 ]
机构
[1] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA
关键词
DOPAMINE D-4 RECEPTOR; DEFICIT/HYPERACTIVITY DISORDER; US CHILDREN; ADHD; METHYLPHENIDATE; ADOLESCENTS; TRANSPORTER; PHARMACOTHERAPY; METAANALYSIS; ASSOCIATION;
D O I
10.1249/JSR.0b013e3182091d79
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
Attention-deficit hyperactivity disorder (ADHD) is a neurobehavioral development disorder affecting an estimated 6% to 9% of youth in the United States. The typical manifestations of ADHD, attention difficulties and hyperactivity, cause impairment in social and academic functioning, while common comorbid conditions can add significantly to the disease burden. Diagnosing ADHD requires a comprehensive clinical approach. Many medications have been shown to provide benefit for patients with ADHD, and a positive response to medication can be an important factor in clarifying the diagnosis. Medical therapy is of particular interest when treating athletes, as competitive bodies ban many treatment options. This review provides the sports medicine provider with a framework for the treatment of ADHD in the athlete.
引用
收藏
页码:32 / 36
页数:5
相关论文
共 50 条